Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Stroke breaks the oxidative balance in the body and causes extra reactive oxygen species (ROS) generation, leading to oxidative stress damage. Long noncoding RNAs (lncRNAs) and microRNAs play pivotal roles in oxidative stress-mediated brain injury. Safflor yellow B (SYB) was able to effectively reduce ischemia-mediated brain damage by increasing antioxidant capacity and inhibiting cell apoptosis. In this study, we investigated the putative involvement of lncRNA AK046177 and microRNA-134 (miR-134) regulation in SYB against ischemia/reperfusion- (I/R-) induced neuronal injury. I/R and oxygen-glucose deprivation/reoxygenation (OGD/R) were established and . Cerebral infarct volume, neuronal apoptosis, and protein expression were detected. The effects of SYB on cell activity, cell respiration, nuclear factor erythroid 2-related factor 2 (Nrf2), antioxidant enzymes, and ROS were evaluated. I/R or OGD/R upregulated the expression of AK046177 and miR-134 and subsequently inhibited the activation and expression of CREB, which caused ROS generation and brain/cell injury. SYB attenuated the effects of AK046177, inhibited miR-134 expression, and promoted CREB activation, which in turn promoted Nrf2 expression, and then increased antioxidant capacities, improved cell respiration, and reduced apoptosis. We suggested that the antioxidant effects of SYB were driven by an AK046177/miR-134/CREB-dependent mechanism that inhibited this pathway, and that SYB has potential use in reducing or possibly preventing I/R-induced neuronal injury.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292966PMC
http://dx.doi.org/10.1155/2020/4586839DOI Listing

Publication Analysis

Top Keywords

safflor yellow
8
brain injury
8
long noncoding
8
ros generation
8
neuronal injury
8
effects syb
8
cell respiration
8
expression
6
syb
6
injury
5

Similar Publications

[Effects of combined use of active ingredients in Buyang Huanwu Decoction on oxygen-glucose deprivation/reglucose-reoxygenation-induced inflammation and oxidative stress of BV2 cells].

Zhongguo Zhong Yao Za Zhi

July 2025

Shanxi University of Chinese Medicine, Key Laboratory of Benefiting Qi and Activating Blood Circulation to Treat Multiple Sclerosis (National Administration of Traditional Chinese Medicine), Neurobiology Research Center Jinzhong 030619, China Key Laboratory of Cellular Physiology (Ministry of Educati

This study aims to explore the effects and action mechanisms of the active ingredients in Buyang Huanwu Decoction(BYHWD), namely tetramethylpyrazine(TMP) and hydroxy-safflor yellow A(HSYA), on oxygen-glucose deprivation/reglucose-reoxygenation(OGD/R)-induced inflammation and oxidative stress of microglia(MG). Network pharmacology was used to screen the effective monomer ingredients of BYHWD and determine the safe concentration range for each component. Inflammation and oxidative stress models were established to further screen the best ingredient combination and optimal concentration ratio with the most effective anti-inflammatory and antioxidant effects.

View Article and Find Full Text PDF

Xuebijing Alleviates Microglial Activation after Traumatic Brain Injury via Regulation of NF-κB Pathway: Network Pharmacology and Experimental Validation.

Comb Chem High Throughput Screen

April 2025

Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Lijiang Road 1, Suzhou City, Jiangsu Province 215153, China.

Objective: Xuebijing (XBJ) injection, a traditional Chinese medicine (TCM) widely used in China for treating sepsis and multiple organ dysfunction, has shown neuroprotective effects in traumatic brain injury (TBI). However, the mechanisms underlying these effects remain unclear. This study aims to elucidate the neuroprotective and pharmacological molecular mechanisms of XBJ and its active monomer, Hydroxy-safflor yellow A (HSYA), in treating TBI through network pharmacology and experimental validation.

View Article and Find Full Text PDF

Detection of Adulterated Tablet () via In-Depth Chemical Analysis and Subsequent Reconstruction of Its Pharmacopoeia Q-Markers.

Molecules

March 2024

School of Chinese Herbal Medicine, Guangzhou Higher Education Mega Center, Guangzhou University of Chinese Medicine, Waihuang East Road No. 232, Guangzhou 510006, China.

Article Synopsis
  • The study focuses on improving the detection of adulteration in the traditional Chinese medicine formula Tablet for stroke treatment, using advanced UHPLC-Q-Orbitrap MS/MS technology.
  • Researchers identified and differentiated 68 compounds, uncovering 11 unexpected ones in the formula, which enhances understanding of its composition.
  • Five adulterated tablets were successfully detected with new quality markers, including hydroxy safflor yellow A and citric acid, proposing a refined quality control system for the Pharmacopoeia Commission.
View Article and Find Full Text PDF

Safflor Yellow A Protects Beas-2B Cells Against LPS-Induced Injury via Activating Nrf2.

Rev Bras Farmacogn

June 2023

The Third Clinical Medical College, Fujian Medical University, Xiamen, 361003 Fujian China.

Acute lung injury and its severe form acute respiratory distress syndrome are lethal lung diseases. So far, effective therapy for the diseases is deficient and the prognosis is poor. Recently, it was found activating nuclear factor erythroid 2-related factor 2 could attenuate the injury including inflammation, oxidative stress, and apoptosis in those diseases.

View Article and Find Full Text PDF

Safflor yellow treating angina pectoris: A pharmacoeconomic evaluation and network meta-analysis.

Medicine (Baltimore)

October 2022

School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu, P.R. China.

Background: Coronary heart disease (CHD) is a cardiovascular disease caused by myocardial ischemia. In China, safflor yellow and artemisinin-based combination therapies have been extensively used to treat angina pectoris.

Methods: Efficacies were provided by a network meta-analysis following the PRISMA 2020 checklist.

View Article and Find Full Text PDF